LANXESS underpins BRIC strategy with two acquisitions in Asia
LANXESS to acquire chemical businesses of Indian company Gwalior Chemical Industries Ltd for EUR 82.4 million
Specialty chemicals group LANXESS AG is underpinning its long-term growth strategy in the BRIC countries with two acquisitions in Asia.
LANXESS subsidiary LANXESS India Private Ltd. will acquire the chemical businesses and assets of stock market listed Indian company Gwalior Chemical Industries Ltd for EUR 82.4 million, including debt. A corresponding agreement was reached with the company. The transaction is subject to formal approval by Gwalior’s shareholders and clearance by the relevant antitrust authorities. Closing is expected at the end of the third quarter of 2009.
LANXESS will also acquire the business and production assets of Chinese-based Jiangsu Polyols Chemical Co. Ltd. Both parties have agreed not to disclose the purchase price. Closing of this transaction is expected in the third quarter of 2009. The medium-sized company, which was founded in 2006, is located in Liyang, west of Shanghai.
“These acquisitions in India and China are further milestones in our company’s long-term growth strategy in the BRIC countries,” said Axel C. Heitmann, Chairman of LANXESS`s Board of Management. “Gwalior’s business complements the portfolio of our Basic Chemicals business unit and our first acquisition in India will strengthen our production base in this exciting market.”
Gwalior is one of the largest Indian producers of benzyl products and one of the leading global producers of sulphur chlorides for the agrochemicals and pharmaceuticals as well as for the flavor and fragrance industries. Its production sites are in Nagda, Madhya Pradesh state, and in Ankleshwar, Gujarat state. In the future, production will be concentrated at the modern Nagda site, which is currently expanding capacities.
LANXESS will acquire Gwalior’s chemical businesses. The acquisition will be financed out of existing liquidity. The transaction is expected to be EPS accretive as of 2010.
Jiangsu Polyols mainly produces trimethylolpropane (TMP) that is used in lubricants, paints, and coatings. LANXESS’s business unit Basic Chemicals is already a major supplier of TMP in China and will integrate Jiangsu into its global operations.
With some 1,000 employees worldwide, the LANXESS Basic Chemicals business unit is one of the leading manufacturers of raw materials for agrochemicals, polymers, surface coatings, and pigments. It operates several production sites in Germany, China, and the United States. The Basic Chemicals business unit belongs to the Advanced Intermediates segment, which achieved total sales in 2008 of EUR 1.3 billion. The segment has proven to be one of LANXESS’ more stable businesses in the economic crisis due to its exposure to the agrochemical industry.
“We have always stated in the past that we are on the look out for small or medium-sized assets that will create value for LANXESS and are a strategic fit for our portfolio,” added Heitmann. “These two transactions follow on from our successful acquisition of Petroflex, one of the leading Latin American synthetic rubber producers.”
LANXESS has a growing presence in India. The headquarters are located in Thane, Maharashtra state, and there is a production site in Madurai, Tamil Nadu state, for leather chemicals, material protection products and the company’s wholly-owned subsidiary Rhein Chemie. LANXESS is also building a new production facility for ion exchange resins and relocating its rubber chemicals site from Thane to Jhagadia, Gujarat state. This project will be completed by 2010 and has an investment volume of roughly EUR 50 million.
LANXESS currently employs some 200 people in India, where the Group had 2008 sales of about EUR 115 million. India is next to China the company’s most important market in Asia, and an integral part of its BRIC strategy. Despite the global economic crisis, India is expected to grow by six percent this year, with a rising middle-class driving demand for chemicals. In 2008, LANXESS achieved sales of about EUR 385 million in China and currently employees about 900 people there. The BRIC countries represented 16 percent of the company’s group sales in 2008.
Most read news
Topics
Organizations
Other news from the department business & finance
These products might interest you

Dursan by SilcoTek
Innovative coating revolutionizes LC analysis
Stainless steel components with the performance of PEEK - inert, robust and cost-effective

OCA 200 by DataPhysics
Using contact angle meter to comprehensively characterise wetting behaviour, solids, and liquids
With its intuitive software and as a modular system, the OCA 200 answers to all customers’ needs

Tailor-made products for specific applications by IPC Process Center
Granulates and pellets - we develop and manufacture the perfect solution for you
Agglomeration of powders, pelletising of powders and fluids, coating with melts and polymers

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
List_of_drugs:_Cb-Ce
UCB Receives EMEA Positive Opinion and FDA Approvable Letter for Keppra® (levetiracetam) Intravenous Administration
Mechanical Completion of New POM Manufacturing Plant in China
Levels of pyrrolizidine alkaloids in herbal teas and teas are too high - The first non-representative results of a BfR research project show that efforts are required to minimise levels

What will solid-state batteries be like in the future? - Solid-state batteries have a lot of potential, but will have to prove their commercial viability in the next five years
PerkinElmer announces new partnership with Pfizer Global Research & Development
